Hepion Pharmaceuticals Inc

CUSIP 426897302COM NEWCTRVGBPQ4 2025

Hepion Pharmaceuticals Inc — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

10.0%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

3 filings · latest Jan 24, 2025

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Jan 24, 2025	Bigger Capital Fund L P	13G	10.0%	1.06M	SEC
2	Nov 14, 2024	Armistice Capital, LLC	13G/A	5.0%	304.6K	SEC
3	Feb 14, 2024	Armistice Capital, LLC	13G	8.7%	418.0K	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Ancora Advisors LLC	1	$0